Opioids

With 4 remaining staffers, CNS-focused Trevena nears end of road

Trevena has whittled its team down to four people, saying goodbye to several C-suite execs amid a strategic review that includes possibly winding down.

Gabrielle Masson Nov 7, 2024 10:40am

FDA approves first DNA test for opioid use disorder risks

Dec 21, 2023 10:18am

Click, Indivior to make digital therapeutics for addiction

Sep 8, 2023 1:13pm

FDA clears Masimo’s opioid overdose prevention monitor

Apr 3, 2023 9:31am

Eagle swoops down to nab chunk of BARDA-backed Enalare

Aug 9, 2022 11:22am

Northwestern University pain relief implant

Dissolving, nerve-cooling device offers drug-free pain relief

Jul 1, 2022 10:22am